METFORMIN FOR THE PREVENTION OF BLADDER CANCER RECURRENCE: IS IT EFFECTIVE?

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HEIDARI FATEMEH; ABBAS ZADE SHAHIN; MIR HOSSEINI SEYED HASSAN; GHADIAN ALIREZA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Nephro-Urology Monthly Year:2016 | Volume:8 | Issue:3 Page(s): 0-0

Download Full-Text

View:

339

Download:

163

Cites:

Information Journal Paper

Title

METFORMIN FOR THE PREVENTION OF BLADDER CANCER RECURRENCE: IS IT EFFECTIVE?

Author(s)

HEIDARI FATEMEH | ABBAS ZADE SHAHIN | MIR HOSSEINI SEYED HASSAN | GHADIAN ALIREZA | Issue Writer Certificate

Keywords

BLADDER TUMOR

METFORMIN

TUMOR RECURRENCE

Abstract

Background: Many methods have been used for preventing and reducing recurrences of bladder cancers. In recent years, some investigators have examined the use of METFORMIN for this purpose. First lines of evidence have shown that METFORMIN inhibits cancer cell growth and prevents cancer occurrence in patients with type 2 diabetes.Objectives: This study is designed to assess METFORMIN usage in the prevention of bladder cancer recurrence after the trans-urethral resection of a BLADDER TUMOR (TUR-T).Patients and Methods: In the present study, METFORMIN was administered in the treatment of 32 patients with a history of bladder cancer, and their results were compared with those of 33 patients with bladder cancer recurrence (placebo group). Patients in the METFORMIN group received 1000 mg METFORMIN (2 tablets 500 mg) for 1 year. Frequency of TUMOR RECURRENCE was calculated and compared with the placebo group.Results: There was no statistical difference between the 2 groups with respect to the recurrence rate (P>0.05). Although the recurrence interval was longer for the METFORMIN group, this increase was not statistical significant (P>0.05). Furthermore, TUMOR RECURRENCE had no correlation with sex or the grade of the tumors.Conclusions: According to our findings, it seems that METFORMIN has no considerable inhibitory effect on the recurrence rate of bladder cancer, but that it can delay TUMOR RECURRENCE.

Cites

No record.

References

SEX DIFFERENCES IN BLADDER CANCER PATHOLOGY AND SURVIVAL: ANALYSIS OF A POPULATION-BASED CANCER REGISTRY

Cite

APA: Copy

HEIDARI, FATEMEH, ABBAS ZADE, SHAHIN, MIR HOSSEINI, SEYED HASSAN, & GHADIAN, ALIREZA. (2016). METFORMIN FOR THE PREVENTION OF BLADDER CANCER RECURRENCE: IS IT EFFECTIVE?. THE JOURNAL OF NEPHRO-UROLOGY MONTHLY, 8(3), 0-0. SID. https://sid.ir/paper/323781/en

Vancouver: Copy

HEIDARI FATEMEH, ABBAS ZADE SHAHIN, MIR HOSSEINI SEYED HASSAN, GHADIAN ALIREZA. METFORMIN FOR THE PREVENTION OF BLADDER CANCER RECURRENCE: IS IT EFFECTIVE?. THE JOURNAL OF NEPHRO-UROLOGY MONTHLY[Internet]. 2016;8(3):0-0. Available from: https://sid.ir/paper/323781/en

IEEE: Copy

FATEMEH HEIDARI, SHAHIN ABBAS ZADE, SEYED HASSAN MIR HOSSEINI, and ALIREZA GHADIAN, “METFORMIN FOR THE PREVENTION OF BLADDER CANCER RECURRENCE: IS IT EFFECTIVE?,” THE JOURNAL OF NEPHRO-UROLOGY MONTHLY, vol. 8, no. 3, pp. 0–0, 2016, [Online]. Available: https://sid.ir/paper/323781/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops